ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
ZimVie Inc. (Nasdaq: ZIMV) has launched its new Immediate Molar Implant System in the United States, expanding its TSX® and T3 PRO® Implant systems portfolio. The innovative system addresses the challenges of replacing extracted molars with implants, offering enhanced precision and control during molar extraction procedures.
The system features specially engineered instrumentation and optimized wide-diameter implants that provide improved primary stability. Its proprietary DAE coronal surface technology potentially reduces peri-implantitis risk by up to 20%. Notably, the system cuts traditional treatment time in half and maintains restorative compatibility with ZimVie's existing implant systems, minimizing switching costs.
ZimVie Inc. (Nasdaq: ZIMV) ha lanciato negli Stati Uniti il suo nuovo Immediate Molar Implant System, ampliando la gamma dei sistemi implantari TSX® e T3 PRO®. Questo sistema innovativo affronta le difficoltà legate alla sostituzione dei molari estratti con impianti, offrendo maggiore precisione e controllo durante le procedure di estrazione molare.
Il sistema include strumenti appositamente progettati e impianti a diametro ampio ottimizzati, che garantiscono una stabilità primaria migliorata. La tecnologia esclusiva DAE sulla superficie coronale riduce potenzialmente il rischio di peri-implantite fino al 20%. Inoltre, il sistema dimezza i tempi tradizionali di trattamento e mantiene la compatibilità con i sistemi implantari esistenti di ZimVie, riducendo così i costi legati al cambio di sistema.
ZimVie Inc. (Nasdaq: ZIMV) ha lanzado en Estados Unidos su nuevo Immediate Molar Implant System, ampliando su portafolio de sistemas de implantes TSX® y T3 PRO®. Este sistema innovador aborda los retos de reemplazar molares extraídos con implantes, ofreciendo mayor precisión y control durante los procedimientos de extracción molar.
El sistema cuenta con instrumentación especialmente diseñada e implantes de diámetro ancho optimizados que proporcionan una estabilidad primaria mejorada. Su tecnología exclusiva de superficie coronal DAE reduce potencialmente el riesgo de periimplantitis hasta en un 20%. Destaca que el sistema reduce a la mitad el tiempo tradicional de tratamiento y mantiene la compatibilidad restaurativa con los sistemas de implantes existentes de ZimVie, minimizando los costos de cambio.
ZimVie Inc. (나스닥: ZIMV)은 미국에서 새로운 Immediate Molar Implant System을 출시하며 TSX® 및 T3 PRO® 임플란트 시스템 포트폴리오를 확장했습니다. 이 혁신적인 시스템은 발치된 어금니를 임플란트로 대체하는 데 따른 어려움을 해결하며, 어금니 발치 시 더 높은 정밀도와 제어를 제공합니다.
이 시스템은 특별히 설계된 기구와 최적화된 넓은 직경의 임플란트를 특징으로 하며, 개선된 초기 안정성을 제공합니다. 독자적인 DAE 관상면 표면 기술은 임플란트 주위염 위험을 최대 20%까지 줄일 수 있습니다. 특히, 이 시스템은 기존 치료 시간을 절반으로 단축하고 ZimVie의 기존 임플란트 시스템과의 복원 호환성을 유지하여 전환 비용을 최소화합니다.
ZimVie Inc. (Nasdaq : ZIMV) a lancé aux États-Unis son nouveau Immediate Molar Implant System, élargissant ainsi sa gamme de systèmes d’implants TSX® et T3 PRO®. Ce système innovant répond aux défis du remplacement des molaires extraites par des implants, offrant une précision et un contrôle accrus lors des procédures d’extraction molaire.
Le système comprend des instruments spécialement conçus et des implants à large diamètre optimisés qui assurent une meilleure stabilité primaire. Sa technologie exclusive de surface coronaire DAE réduit potentiellement le risque de péri-implantite jusqu’à 20 %. Notamment, ce système réduit de moitié le temps de traitement traditionnel tout en conservant la compatibilité restauratrice avec les systèmes d’implants existants de ZimVie, minimisant ainsi les coûts liés au changement.
ZimVie Inc. (Nasdaq: ZIMV) hat in den USA sein neues Immediate Molar Implant System eingeführt und erweitert damit sein Portfolio der TSX®- und T3 PRO®-Implantatsysteme. Das innovative System geht die Herausforderungen bei der Ersetzung extrahierter Molaren mit Implantaten an und bietet verbesserte Präzision und Kontrolle während der Molarenextraktionsverfahren.
Das System verfügt über speziell entwickelte Instrumente und optimierte Implantate mit großem Durchmesser, die eine verbesserte Primärstabilität bieten. Die firmeneigene DAE-Kronenoberflächentechnologie reduziert potenziell das Risiko einer Periimplantitis um bis zu 20 %. Bemerkenswert ist, dass das System die herkömmliche Behandlungszeit halbiert und die restaurative Kompatibilität mit den bestehenden Implantatsystemen von ZimVie beibehält, wodurch Wechselkosten minimiert werden.
- New system reduces traditional molar implant treatment time by 50%
- Proprietary technology reduces peri-implantitis risk by up to 20%
- Compatible with existing implant systems, minimizing switching costs for providers
- Addresses specific market need in molar restoration segment
- None.
Insights
ZimVie's new system enables immediate molar implant placement, cutting treatment time by half with 20% lower peri-implantitis risk.
ZimVie's Immediate Molar Implant System addresses a significant clinical challenge in dental implantology. Traditionally, after molar extraction, patients must wait months before implant placement due to the complex multi-rooted anatomy of molar sites. This new system fundamentally changes this approach.
The innovation offers two key technical advancements: First, the specially engineered instrumentation provides greater control and predictability during site preparation following molar extraction. Second, the optimized wide-diameter implants better match molar extraction sites, delivering enhanced primary stability—a critical factor for successful osseointegration.
The system's proprietary DAE coronal surface technology potentially reduces peri-implantitis risk by up to 20%. This is clinically significant as peri-implantitis remains one of the leading causes of long-term implant failure.
From a practical standpoint, the system reduces treatment time by half compared to conventional protocols. This streamlines the patient care pathway while maintaining restorative compatibility with ZimVie's existing implant systems, allowing practitioners to implement this solution without significant workflow disruption or additional inventory management challenges.
ZimVie's product expansion strengthens dental portfolio with technology that addresses clinical challenges while building on existing product lines.
ZimVie's launch of the Immediate Molar Implant System represents a strategic expansion of their dental implant portfolio. By building upon their established TSX® and T3 PRO® platforms, the company maximizes their existing technological investments while addressing a specific clinical challenge.
The innovation is particularly notable for its integrated approach to the molar replacement workflow. Rather than introducing an isolated product, ZimVie has developed a comprehensive system that includes both specialized instrumentation and optimized implants designed specifically for molar sites.
The system's backward compatibility with existing ZimVie implant infrastructure is strategically significant. This "minimizes switching costs" for current customers, potentially accelerating clinical adoption by removing barriers to implementation.
From a technological differentiation perspective, the proprietary DAE coronal surface technology that potentially reduces peri-implantitis risk by 20% addresses a significant clinical concern. This focus on improving long-term outcomes aligns with the industry's shift toward value-based solutions.
The ability to reduce treatment time by half compared to traditional protocols represents a meaningful workflow improvement that benefits both practitioners and patients, addressing efficiency challenges in dental practice management while improving the patient experience.
Innovative dental implant system offers new level of precision, control, and stability
PALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in the United States. ZimVie is expanding its already clinically proven TSX® and T3 PRO® Implant systems with an immediate molar solution, simplifying challenging clinical scenarios for providers and shortening treatment times for patients requiring molar implants.
Immediately replacing extracted molars with an implant can be difficult due to the complex multi-rooted anatomy and size of the tooth socket. ZimVie’s Immediate Molar Implant System includes specially engineered instrumentation that streamlines site preparation in molar extraction, making it a more controlled and predictable procedure. The system also offers optimized wide-diameter implants that better fit the implant site for unmatched primary stability while potentially reducing the risk of peri-implantitis by up to
Conventional treatment protocols involve molar extraction, followed by months of healing before an implant can be placed. The ZimVie Immediate Molar Implant System allows the implant to be restored in half the time compared to traditional treatment, in a simplified, predictable manner.
“The launch of our Immediate Molar Dental Implant System marks a significant milestone in our commitment to advancing dental technology,” said ZimVie CEO Vafa Jamali. “We have expanded the offering of our implant systems to address the unique challenges of molar tooth restoration and provide patients shorter and more cost-effective treatment while delivering a more predictable, lasting outcome.”
For more information on ZimVie’s dental implants, suite of connected solutions, and continuing education, please visit www.zimvie.com.
A Media Snippet accompanying this announcement is available by clicking on this link.
About TSX Implants
Launched in 2022, TSX Implants are designed for immediate extraction and standard loading protocols as well as placement predictability and primary stability in soft and dense bone. The Implant incorporates features with more than two decades of real-world, clinical data to deliver peri-implant health, crestal bone maintenance, long-term osseointegration, and prosthetic stability,* including the Contemporary Hybrid Surface combination with coronal DAE. Integrated with ZimVie’s end-to-end digital workflows and engineered with surgical and restorative versatility, the TSX Implant furthers ZimVie’s commitment to simplify procedures and optimize practice protocols.
About T3 PRO Implants
Launched in 2022, the T3 PRO Implant’s advanced design delivers high primary stability and allows for immediate function. T3 PRO has a hybrid surface featuring the proprietary Osseotite surface on the implant collar, as well as a rougher grit-blasted implant body. Not only have multiple long-term, independent clinical studies on the proprietary Osseotite surface demonstrated safety and performance,* they have also demonstrated the effect of this surface in preserving crestal bone. This Contemporary Hybrid Surface of T3 PRO along with the optional integrated platform switching design has also been shown to provide early and long-term peri-implant bone support.
* References on file at ZimVie.
About ZimVie
ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at www.zimvie.com. Follow @ZimVie on Twitter, Facebook, LinkedIn, or Instagram.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.
Media Contact Information:
ZimVie
Grace Flowers • Grace.Flowers@ZimVie.com
(561) 319-6130
Investor Contact Information:
Gilmartin Group LLC
Webb Campbell • Webb@gilmartinir.com
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/99f92dfd-d794-4c29-96e4-209f3a10cd03
FAQ
What are the key benefits of ZimVie's (ZIMV) new Immediate Molar Implant System?
How much faster is ZIMV's new molar implant treatment compared to traditional methods?
What technology does ZIMV use to reduce peri-implantitis risk in their new implant system?
How does ZimVie's Immediate Molar Implant System address extraction challenges?
